3 Biotech Stocks That Soared This Week: Are They Buys? [The Motley Fool]
Arcus Biosciences, Inc. (RCUS)
Last arcus biosciences, inc. earnings: 3/5 04:10 pm
Check Earnings Report
Company Research
Source: The Motley Fool
The COVID-9 coronavirus. Presidential campaigns. Uncertainty about what the Federal Reserve Board will do with interest rates. All of these factors have weighed on investors' minds as the stock market pulled back this week. But some stocks zoomed higher instead of pulling back. Three biotech stocks that absolutely soared this week were Arcus Biosciences ( NYSE:RCUS Avadel Pharmaceuticals NASDAQ:AVDL Abeona Therapeutics NASDAQ:ABEO Image source: Getty Images. . Arcus Biosciences Shares of Arcus Biosciences skyrocketed 5% higher this week. Most of this huge jump came after Mizuho Securities' analyst Mara stein reiterated a buy rating on Arcus with a one-year price target of $, twice as high as the biotech stock's closing price in the previous week. Arcus boasts a robust pipeline for a clinical-stage biotech. Its lead candidate is AB98, which is being evaluated in several early- and mid-stage clinical studies for treating multiple types of cancer. The biotech expects to announce results
Show less
Read more
Impact Snapshot
Event Time:
RCUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCUS alerts
High impacting Arcus Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RCUS
News
- Shareholders in Arcus Biosciences (NYSE:RCUS) have lost 65%, as stock drops 9.9% this past week [Yahoo! Finance]Yahoo! Finance
- Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Arcus Biosciences Announces New Employment Inducement GrantsBusiness Wire
- Adenosine Antagonists Clinical Trial Pipeline Analysis: 10+ Key Companies Shaping the Future of Adenosine Antagonists Therapeutics | DelveInsight [Yahoo! Finance]Yahoo! Finance
RCUS
Earnings
- 11/6/24 - Beat
RCUS
Sec Filings
- 12/20/24 - Form 4
- 12/17/24 - Form SC
- 12/17/24 - Form 4
- RCUS's page on the SEC website